Log In
Print this Print this

Ontinua ER, arbaclofen (OS-440)

Also known as: formerly Arbaclofen ER

  Manage Alerts
Collapse Summary General Information
Company Osmotica Pharmaceutical Corp.
DescriptionExtended-release tablet of arbaclofen, a GABA B receptor agonist
Molecular Target GABA B receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat patients with spasticity due to multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today